Back to School: How biopharma can reboot drug development. Access exclusive analysis here

Zynaxis deal

ZNXS and Secretech Inc. reached an agreement in principle to merge the Birmingham, Ala., company with ZNXS for 3 million shares of

Read the full 228 word article

Trial Subscription

Get a two-week free trial subscription to BioCentury

SIGN UP

Article Purchase

This article may not be distributed to non-subscribers
More Info >PURCHASE